Author:
Fayura Lyubov R.,Boretsky Yuriy R.,Pynyaha Yuriy V.,Wheatley Denys N.,Sibirny Andriy A.
Subject
Applied Microbiology and Biotechnology,General Medicine,Biotechnology,Bioengineering
Reference29 articles.
1. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion;Cheng;Cancer Res.,2007
2. Regression of hepatocellular cancer in a patient treated with arginine deiminase;Curley;Hepatogastroenterology,2003
3. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production;Dillon;Med. Sci. Monit.,2002
4. Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation;Dillon;Cancer,2004
5. Pegylated arginine deiminase (ADI-SS PEGv20,000mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo;Ensor;Cancer Res.,2002
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献